TNF Pharmaceuticals, Inc. (LON:0A8D)
London · Delayed Price · Currency is GBP · Price in USD 0.1030
-0.0084 (-7.54%)
At close: Jul 14, 2025
TNF Pharmaceuticals Market Cap
TNF Pharmaceuticals has a market cap or net worth of 1.12 million as of July 16, 2025. Its market cap has decreased by -67.21% in one year.
Market Cap
1.12M
Enterprise Value
689.60K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since April 20, 2021, TNF Pharmaceuticals's market cap has decreased from 142.21M to 1.12M, a decrease of -99.21%. That is a compound annual growth rate of -68.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 1.12M | -55.56% |
| Dec 31, 2024 | 2.53M | -75.52% |
| Dec 29, 2023 | 10.34M | -72.56% |
| Dec 30, 2022 | 37.67M | -77.64% |
| Dec 31, 2021 | 168.49M | 18.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 165.33B |
| HSBC Holdings | 160.17B |
| Shell | 155.39B |
| Unilever | 113.16B |
| British American Tobacco p.l.c. | 84.22B |
| Rolls-Royce Holdings | 83.30B |
| Rio Tinto Group | 75.72B |
| RELX PLC | 73.43B |